REFERENCES
- Cervera R, Piette J C, Font J, et al. APS: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 2002; 46: 1019–1027
- Wilson W A, Gharavi A E, Koike T, et al. International consensus statement on preliminary classification criteria for definite APS. Arthritis Rheum 1999; 42: 1309–1311
- Hanly JG. APS: an overview. Can Med Assoc J 2003; 168: 13
- Sanna G, Bertolaccini M L, Hughes G RV. Hughes syndrome, the APS. A new chapter in neurology. Ann NY Acad Sci 2005; 1051: 465–486
- Sanna G, Bertolaccini M L, Cuadrado M J, et al. Central nervous system involvement in the antiphospholipid (Hughes) syndrome. Rheumatology 2003; 42: 200–213
- Harel M, Aron-Maor A, Sherer Y, et al. The infectious etiology of the antiphospholipid syndrome: links between infection and autoimmunity. Immunobiology 2005; 210: 743–747
- Kupferwasser L I, Hafner G, Mohr-Kahaly S, et al. The presence of infection-related antiphospholipid antibodies in infective endocarditis determines a major risk factor for embolic events. J Am Coll Cardiol 1999; 33: 1365–1371
- Lev S, Shoenfeld Y. Cardiac valvulopathy in the APS. Clin Rev Allergy Immunol 2002; 23: 341–348
- Cervera R. Coronary and valvular syndromes and antiphospholipid antibodies. Thromb Res 2004; 114: 501–507
- Tincani A, Biasini-Rebaioli C, Cattaneo R, et al. Nonorgan specific autoantibodies and heart damage. Lupus 2005; 14: 656–659
- Afek A, Shoenfeld Y, Manor R, et al. Increased endothelial cell expression of α 3β 1 integrin in cardiac valvulopathy in the primary (Hughes) and secondary APS. Lupus 1999; 8: 502–507
- Blank M, Krause I, Fridkin M, et al. Bacterial induction of autoantibodies toβ 2-glycoprotein-I accounts for the infectious etiology of APS. J Clin Inves 2002; 109: 797–804
- Geraci J E, Wilkowske C J, Washington J A. Haemophilus endocarditis. Report of 14 patients. Mayo Clin Proc 1977; 52: 209–215
- Darras-Joly C, Lortholary O, Mainardi J L, et al. Haemophilus endocarditis: Report of 42 cases in adults and review. Clin Infect Dis 1997; 24: 1087–1094
- Asherson R, Cervera R. Catastrophic APS. Curr Rheumatol Rep 2003; 5: 395–400
- Turiel M, Sarzi-Puttini P, Peretti R, et al. Five year follow up by transesophageal echocardiographic studies in primary APS. Am J Cardiol 2005; 96: 574–579
- Georgiou G M, Ioannides M A, Konis P A, et al. Nonbacterial vegetations in a young patient with primary APS. Hellenic J Cardiol 2005; 46: 435–438
- Hess D C. Stroke associated with antiphospholipid antibodies. Stroke 1992; 23: I23–I28
- Moster M. Coagulopathies and arterial stroke. J Neuroophthalmol 2003; 23: 63–71
- Boudoulas H. Etiology of valvular heart disease. Expert Rev Cardiovasc Ther 2003; 1(4)523–532
- Greene J N, Sandin R L, Villanueva L, et al. Haemophilus parainfluenzae endocarditis in a patient with mitral valve prolapse. Ann Clin Lab Sci 1993; 23: 203–206
- Hawkins C, Gatenby P, Tuck R, et al. Cerebrovascular disease associated with antiphospholipid antibodies: more questions than answers. J Autoim Dis 2006; 3: 3
- Oill P A, Chow A W, Guze L B. Adult bacteremic Haemophilus parainfluenzae infections. Seven reports of cases and a review of the literature. Arch Intern Med 1979; 139: 985–988